7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Disease in HIV-AIDS ... avium complex (MAC ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Disease in HIV-AIDS ... avium complex (MAC ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
treated patients are still ... optimization of ART may ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
of Disseminated MAC ... Treating Disseminated MAC ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Activation Syndrome (MAS ... A subset of hemophagocytic ... Still disease ... manifestation of MAS ... Plasma exchange #MAS
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
: • If used, may ... Severe Disseminated Disease ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
weight-based, 900 mg max ... weekly (900 mg max ... Adolescent ARV Guidelines ... #opportunistic ... #infections #HIVAIDS